Moreover, the pharmacology on the Lively factors was mainly uncharacterized, and confirmation of SCB use was hindered by an absence of identified biomarkers. These awareness gaps prompted researchers across several disciplines to speedily (1) keep an eye on, detect and quantify with chromatography/mass spectrometry the at any time-shifting contents